The median overall survival rate was significantly longer in the TPF arm (18.6 months) than in the PF arm (14.2 months) for patients diagnosed with squamous cell carcinoma of the head and neck who underwent treatment with docetaxel.
UNCOMMONsideeffects
blistering skin, numbness,
tingling, or burning sensation in the hands or feet,
weakness in the hands and feet, unusual bleeding or bruising,
nosebleeds, blurred vision,
loss of vision
Docetaxel
(Lung Cancer, Laryngeal Cancer, Prostate Cancer)
Docetaxel is administered via a one-hour infusion every three weeks over ten or more cycles.
COMMONsideeffects
nausea, vomiting,
diarrhea, constipation,
changes in taste, extreme tiredness,
muscle/joint/bone pain, hair loss,
nail changes, increased eye tearing,
sores in the mouth and throat
Do you want to show doctors in your area?
We are sorry but your curent location dosen't have a postal code atached. We cannot display doctors in your area.
